Repligen Corp (RGEN)
157.14
+0.08
(+0.05%)
USD |
NASDAQ |
Apr 19, 16:00
157.26
+0.12
(+0.08%)
After-Hours: 20:00
Repligen Revenue (Quarterly): 155.74M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 155.74M |
| September 30, 2023 | 141.19M |
| June 30, 2023 | 159.17M |
| March 31, 2023 | 182.66M |
| December 31, 2022 | 186.76M |
| September 30, 2022 | 200.74M |
| June 30, 2022 | 207.63M |
| March 31, 2022 | 206.40M |
| December 31, 2021 | 186.52M |
| September 30, 2021 | 178.22M |
| June 30, 2021 | 162.96M |
| March 31, 2021 | 142.84M |
| December 31, 2020 | 108.65M |
| September 30, 2020 | 94.06M |
| June 30, 2020 | 87.46M |
| March 31, 2020 | 76.09M |
| December 31, 2019 | 69.47M |
| September 30, 2019 | 69.44M |
| June 30, 2019 | 70.69M |
| March 31, 2019 | 60.63M |
| December 31, 2018 | 51.94M |
| September 30, 2018 | 49.53M |
| June 30, 2018 | 47.73M |
| March 31, 2018 | 44.83M |
| December 31, 2017 | 41.61M |
| Date | Value |
|---|---|
| September 30, 2017 | 36.58M |
| June 30, 2017 | 32.46M |
| March 31, 2017 | 30.59M |
| December 31, 2016 | 25.60M |
| September 30, 2016 | 24.68M |
| June 30, 2016 | 29.17M |
| March 31, 2016 | 25.09M |
| December 31, 2015 | 21.45M |
| September 30, 2015 | 19.81M |
| June 30, 2015 | 21.46M |
| March 31, 2015 | 20.82M |
| December 31, 2014 | 16.39M |
| September 30, 2014 | 15.28M |
| June 30, 2014 | 15.55M |
| March 31, 2014 | 16.33M |
| December 31, 2013 | 15.38M |
| September 30, 2013 | 18.82M |
| June 30, 2013 | 17.51M |
| March 31, 2013 | 16.46M |
| December 31, 2012 | 18.81M |
| September 30, 2012 | 15.10M |
| June 30, 2012 | 15.52M |
| March 31, 2012 | 12.82M |
| September 30, 2011 | 8.631M |
| June 30, 2011 | 7.654M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
69.44M
Minimum
Sep 2019
207.63M
Maximum
Jun 2022
141.41M
Average
155.74M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Retractable Technologies Inc | 14.29M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
| Catheter Precision Inc | 0.128M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.49M |
| Total Expenses (Quarterly) | 155.93M |
| EPS Diluted (Quarterly) | -0.46 |
| Enterprise Value | 8.592B |
| Gross Profit Margin (Quarterly) | 43.41% |
| Profit Margin (Quarterly) | -16.37% |
| Earnings Yield | 0.46% |
| Operating Earnings Yield | 0.27% |
| Normalized Earnings Yield | 0.0877 |